Virbac offers veterinarians, farmers, and pet owners a range of products and services focused on animal health, covering various species and diseases, self-described as contributing to the future of animal health.

Virbac

Ark Naturals offers a range of premium pet products, including health supplements and wellness items aimed at keeping pets healthy.

Ark Naturals

IDEXX provides diagnostic and software products and services for pet healthcare, self-described as a global leader in veterinary innovation.

David Evans Shaw

IDEXX

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

Metric
Company Name	Virbac	Ark Naturals	IDEXX	QuidelOrtho Corporation
Symbol				QDEL
MSH ID	COM:VIRBAC	COM:ARKNATURALS	COM:IDEXX	COM:QUIDELORTHO
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Consumer Goods	Healthcare & Health Services	Healthcare
Industry	Veterinary	Pet Care	Veterinary Care	Medical - Instruments & Supplies
Country	FR	US	US	US
Stage
Employee Count			7.37K	7.10K
Website	virbac.com	arknaturals.com	idexx.com	quidelortho.com
LinkedIn
Founders

Metric
Market Cap			2.01B
Enterprise Value
Monthly Web Traffic	131	253.55K
Web Traffic Growth	-0.47	-0.32
Valuation
Raised Capital

Metric
Revenue				2.99B
Revenue (LTM)
Revenue (NTM)
Gross Profit				1.28B
EBITDA				703.50M
Operating Income				246.30M
Net Income				-10.10M
EPS				-0.15
Diluted EPS				-0.15
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.48
Operating Profit Margin				0.05
EBITDA Margin				0.24
Net Profit Margin				-0.00
Return on Equity				-0.00
Return on Assets				-0.00
Return on Capital Employed				0.02

COM:VIRBAC

Virbac

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				344.14
P/B Ratio				0.91
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				1.10
EV Multiple				1.77

Metric
Days Sales Outstanding				38.73
Days Payables Outstanding				59.21
Days Inventory Outstanding				134.78
Operating Cycle				197.80
Cash Conversion Cycle				145.07
Asset Turnover				0.43

Metric
Operating Cash Flow				280.20M
Free Cash Flow				70.90M
Cash Flow to Debt				0.11
Operating Cash Flow/Sales				0.09
Free Cash Flow Yield				0.04

Metric
Cash & Equivalents				118.90M
Accounts Receivable				160M
Inventory				577.80M
Goodwill				2.49B
Debt to Capitalization				0.46
Debt to Assets				0.31
Current Ratio				1.59
Quick Ratio				0.81

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.01
R&D to Revenue				0.08
SG&A to Revenue				0.01